Pharmaceutical powder technology - From art to science: The challenge of the FDA's process analytical technology initiative

Advanced Powder Technology

Volumn 16, Issue 1, 2005, Pages 3-25

  Leuenberger, H ^a   Lanz, M ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Artificial neural networks; Design of experiments; First principles; Freeze drying; Granulation end point; PAT initiative; Percolation theory; Robust formulations; Scale up

Indexed keywords

DRUG DOSAGE; INFORMATION TECHNOLOGY; MATHEMATICAL MODELS; NANOTECHNOLOGY; NEURAL NETWORKS; NUMBER THEORY; PERCOLATION (FLUIDS); PHARMACOKINETICS; POWDER COATINGS; PRECIPITATION (CHEMICAL);

DESIGN OF EXPERIMENTS; FIRST PRINCIPLES; FREEZE-DRYING; GRANULATION END-POINT; PAT INITIATIVE; PERCOLATION THEORY; PHARMACEUTICAL POWDER TECHNOLOGY; PROCESS ANALYST TECHNOLOGY (PAT); ROBUST FORMULATION;

DRUG PRODUCTS;

EID: 15744392762     PISSN: 09218831     EISSN: None     Source Type: Journal    
DOI: 10.1163/1568552053166683     Document Type: Review

References (30)

1. O. Molerus, History of civilisation in the western hemisphere from the point of view of particulate technology, Advanced Powder Technol. 7, 71-78 (1996).
2. H. Rumpf, Mechanische Verfahrenstechnik. Hanser, München (1975).
3. A. S. Hussain, A Collaborative search for efficient methods of ensuring unchanged product quality and performance during scale-up of immediate-release solid oral dosage forms, in: Pharmaceutical Process Scale-Up, M. Levin (Ed.), pp. 325-352. Marcel Dekker, New York (2002).
4. J. von Orelli and H. Leuenberger, Search for technological reasons to develop a capsule or a tablet formulation: (preformulation) case study with a poorly wettable model drug, Int. J. Pharm. (2004) (accepted).
5. H. Leuenberger, Einführung in die mathematischen Grundbegriffe, in: Pharmazeutische Technologie, H. Sucker and P. Speiser (Eds), pp. 1-92. Thieme, Stuttgart (1978).
6. A. S. Hussain, X. Yu and R. D. Johnson, Application of neural computing in pharmaceutical product development, Pharm. Res. 8, 1248-1252 (1991).
7. J. Bourquin, H. Schmidli, P. Van Hoogevest and H. Leuenberger, Comparison of ANN with classical modeling techniques using different experimental designs and data from a galenical study on a solid dosage form, Eur. J. Pharm. Sci. 6, 287-301 (1998).
8. J. Bourquin, H. Schmidli, P. Van Hoogevest and H. Leuenberger, Application of Artificial Neural Networks (ANN) in the development of solid dosage forms, Pharm. Dev. Technol. 2, 111-121 (1997).
9. H. Leuenberger, The application of percolation theory in powder technology, Advanced Powder Technol. 10, 323-352 (1999).
10. H. Leuenberger, M. Usteri, G. Imanidis and S. Winzap, Monitoring the granulation process: granulate growth, fractal dimensionality and percolation threshold, Boll. Chem. Farm. 128, 54-61 (1989).
11. L. Sukowski, NIR based process analytical technology: in-line residual moisture determination for a complete batch inspection of lyophilized end-products. Thesis, Basel (2003).
12. H. Leuenberger, Spray freeze drying - the process of choice for low water soluble drugs? J. Nanoparticle Res. 4, 111-119 (2002).
13. H. Leuenberger and H. P. Bier, Bestimmung der optimalen Menge Granulierflüssigkeit durch Messung der elektrischen Leistungsaufnahme eines Planetenmischers, Acta Pharm. Techn. 7 (suppl.), 41-44 (1979).
14. H. Leuenberger and G. Imanidis, Steuerung der Granulatherstellung im Mischer durch Leistungsmessung, Chem. Ind. XXXVI, 281-284 (1984).
15. G. Betz, P. Junker Bürgin and H. Leuenberger, Power consumption profile analysis and tensile strength measurements during moist agglomeration, Int. J. Pharm. 252, 11-25 (2003).
16. H. Leuenberger, Scale-up in the field of granulation and drying, in: Pharmaceutical Process Scale-Up, M. Levin (Ed.), pp. 151-170. Marcel Dekker, New York (2002).
17. H. Leuenberger, New trends in the production of pharm granules: The classical batch concept and the problem of scale-up/batch versus continuous processing, Eur. J. Pharm. Biopharm. 52, 279-296 (2001).
18. J. Werani et al., Semi-continuous granulation - the process of choice for the production of pharm. granules? Powder Technol. 140, 163-168 (2004).
19. M. Levin and M. Zlokarnik, Dimensional analysis of the tableting process, in: Pharmaceutical Process Scale-Up, M. Levin (Ed.). Marcel Dekker, New York (2002).
20. A. Martin, Physikalische Pharmazie, 4th German edition, H. Leuenberger (Ed.). Wissenschaftliche Verlagsgesellschaft, Stuttgart (2002).
21. Y. Jin, G. Jimbo, M. Kwauk and Y. Kousaka (Eds), in: Proc.'96 China-Japan Symposium on Particuology, Tsinghua University, Beijing (1996).
22. The Journal China Particuology (ISSN: 1672-2515) sponsored by Chinese Society of Particuology (see Aims and Scope), p. 1.
23. H. Leuenberger, Powder - the fourth state of matter? Pharm. Technol., Japan 18, 995-1001 (2002).
24. W. Göpel and H.-D. Wiemhöfer, Statistische Thermodynamik. Spektrum Akademischer Verlag, Heidelberg (2000).
25. H. Burkhart, S. Rizzotti, M. Lanz and H. Leuenberger, LivingFormulae and PhysPharm: a tool for science education and its application, in: Proc. 3rd Int. Conf. on New Learning Technologies, Fribourg, Switzerland (2001).
26. P. W. Atkins, Physical Chemistry. Oxford University Press, Oxford (1998).
27. A. Weber, J. Tschernjaew, M. Beutin and R. Kümmel, Fine particle production by precipitation with compressed or supercritical fluids, in: Proc. 1st Eur. Symp. on Process Technology in Pharmaceutical and Nutritional Sciences, Nürnberg, pp. 121-130 (1998).
28. W. Parmentier, Untersuchungen zur Interpretation von Kraft-Weg- Diagrammen, Pharm. Ind. 40, 860-865 (1978).
29. R. W. Heckel, Density-pressure relationship in powder compaction, Trans. Met. Soc., AIME 221, 671-675 (1961).
30. M. Kuentz and H. Leuenberger, Pressure susceptibility of polymer tablets as a critical property: a modified Heckel equation, J. Pharm. Sci. 88, 174-179 (1999).